Cover Image
Market Research Report

Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019

Published by GervanoRA Data Services LLP Product code 833000
Published Content info 103 Pages
Delivery time: 1-2 business days
Price
Back to Top
Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019
Published: April 26, 2019 Content info: 103 Pages
Description

The Green Tea Extract (EGCG) - Opportunity Assessments in Nutraceuticals, Cosmetics and Pharmaceuticals, H1 2019 report provides in-depth insights with respect to the three major applications and is built to provide strategically important competitor information, analytics, and insights to formulate effective counter research and development strategies. The report offers comprehensive analytics on GTE competitive space by covering nutraceuticals, cosmetics and pharmaceutical segments to assess the unmet needs, drivers, restrains and opportunities.

The following segments provide detailed analytics covering the overall GTE competitive space:

  • Key Events in GTE competitive space
  • Major Drivers, Restraints and Unmet Needs & Opportunities
  • GTE Industry overview
  • Developments and Trends in its Extraction Technologies
  • End Use Opportunity Assessment
  • Clinical Developments
  • Competitive Landscape of Companies
  • Key Companies SWOT Analysis

Report is concentrated more on providing the future favorable opportunities and growth that can be expected in the Green Tea Extract (GTE) market.

Table of Contents
Product Code: GERPH1312

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. REPORT DESCRIPTION
  • 1.2. METHODOLOGY
  • 1.3. ABOUT US: GERVANORA DATA SERVICES

2. EXECUTIVE SUMMARY

  • 2.1. REPORT SUMMARY
  • 2.2. KEY EVENTS IN GREEN TEA EXTRACT COMPETITIVE SPACE- RECENT DEVELOPMENTS
    • 2.2.1. KEY EVENTS IN THE PHARMACEUTICAL DOMAIN
    • 2.2.2. KEY EVENTS IN THE NUTRACEUTICAL DOMAIN
    • 2.2.3. KEY EVENTS IN THE COSMETICS DOMAIN
  • 2.3. MAJOR FINDINGS
    • 2.3.1. DRIVERS
    • 2.3.2. RESTRAINTS
    • 2.3.3. UNMET NEEDS AND OPPORTUNITIES

3. GREEN TEA EXTRACT OVERVIEW

  • 3.1. GENERAL CONSIDERATIONS
    • 3.1.1. BRIEF INTRODUCTION OF GREEN TEA EXTRACT
    • 3.1.2. COMPOSITION OF GREEN TEA EXTRACT
      • 3.1.2.1 EC (EPICATECHIN)
      • 3.1.2.2 EGC (EPIGALLOCATECHIN)
      • 3.1.2.3 ECG (EPICATECHIN GALLATE)
      • 3.1.2.4 EGCG (EPIGALLOCATECHIN-3-GALLATE)
      • 3.1.2.5 OTHER POLYPHENOLS
      • 3.1.2.6 CAFFEINE
    • 3.1.3. OVERVIEW OF GREEN TEA EXTRACT INDUSTRY - FUTURE PERSPECTIVES

4. GREEN TEA EXTRACT TECHNOLOGIES

  • 4.1. DEVELOPMENTS IN GREEN TEA EXTRACTION TECHNOLOGIES
  • 4.2. TRENDS IN GREEN TEA EXTRACTION TECHNOLOGIES- CURRENT STATUS AND FUTURE PROSPECTS

5. GREEN TEA EXTRACT OPPORTUNITIES ASSESSMENT (END USE OR APPLICATION SEGMENT)

  • 5.1. GREEN TEA EXTRACT OPPORTUNITIES IN NUTRACEUTICAL
    • 5.1.1. EGCG APPLICATIONS IN NUTRACEUTICAL
      • 5.1.1.1 DIETARY SUPPLEMENTAL PILLS
      • 5.1.1.2 FUNCTIONAL FOODS
      • 5.1.1.3 ENERGY DRINKS
  • 5.2. GREEN TEA EXTRACT OPPORTUNITIES IN COSMETICS
    • 5.2.1. EGCG APPLICATIONS IN COSMETICS
      • 5.2.1.1 PERSONAL CARE PRODUCTS
      • 5.2.1.2. BEAUTY SUPPLEMENTS
  • 5.3. GREEN TEA EXTRACT OPPORTUNITIES IN PHARMACEUTICALS
    • 5.3.1. EGCG APPLICATIONS IN PHARMACEUTICALS
      • 5.3.1.1 INDICATION WISE APPLICATIONS

5.3.1.1.1 APPLICATIONS IN ONCOLOGY

5.3.1.1.2 APPLICATIONS IN CARDIOVASCULAR

5.3.1.1.3 APPLICATIONS IN METABOLIC DISORDERS

5.3.1.1.4 APPLICATIONS IN INFLAMMATORY SKIN DISEASES

5.3.1.1.5 APPLICATIONS IN NEURODEGENERATIVE DISEASES

5.3.1.1.6 APPLICATIONS IN OBESITY

6. CLINICAL DEVELOPMENTS

  • 6.1. CLINICAL DEVELOPMENTS IN PHARMACEUTICALS
  • 6.2. CLINICAL DEVELOPMENTS IN NUTRACEUTICALS
  • 6.3. CLINICAL DEVELOPMENTS IN COSMETICS

7. OVERVIEW OF COMPETITIVE SEGMENT

  • 7.1. ESTABLISHED COMPANIES AND SWOT
    • 7.1.1. INDENA S.P.A
    • 7.1.2. TAIYO INTERNATIONAL
    • 7.1.3. BLUE CALIFORNIA
    • 7.1.4. HUNAN SUNFULL BIO-TECH CO. LTD
    • 7.1.5. TATE AND LYLE
    • 7.1.6. ROYAL DSM
    • 7.1.7. APPLIED FOOD SCIENCES, INC

8. ABBREVIATIONS

LIST OF FIGURES

  • FIGURE 01: PAST EVENTS IN THE GTE PHARMACEUTICAL MARKET SPACE, 2006 TILL DATE
  • FIGURE 02: FUTURE ESTIMATED PIPELINE MOLECULE APPROVALS
  • FIGURE 03: KEY EVENTS IN THE NUTRACEUTICAL MARKET SPACE
  • FIGURE 04: KEY EVENTS IN THE COSMETICS MARKET SPACE
  • FIGURE 05: TRADITIONAL GREEN TEA EXTRACTION TECHNIQUES
  • FIGURE 06: ADVANCED GREEN TEA EXTRACTION TECHNOLOGIES
  • FIGURE 07: EGCG OPPORTUNITIES IN COSMETICS
  • FIGURE 08: INDENA MARKET OVERVIEW, GLOBAL
  • FIGURE 09: ANNUAL REVENUES (FY ENDED MARCH IN $M), TATE AND LYLE
  • FIGURE 10: ANNUAL REVENUES BY BUSINESS SEGMENTS, TATA AND LYLE
  • FIGURE 11: ANNUAL REVENUES SHARE OF BUSINESS SEGMENTS, DSM
  • FIGURE 12: DSM SALES BY DESTINATION REGIONS

LIST OF TABLES

  • TABLE 01: UNIVERSITIES AND INSTITUTES IN GTE RESEARCH
  • TABLE 02: EGCG OPPORTUNITIES IN OBESITY CONTROL
  • TABLE 03: EGCG OPPORTUNITIES IN ONCOLOGY
  • TABLE 04: EGCG OPPORTUNITIES IN DIABETES
  • TABLE 05: EGCG OPPORTUNITIES IN NEURODEGENERATIVE DISEASES
  • TABLE 06: EGCG OPPORTUNITIES IN LIVER DISEASES
  • TABLE 07: ASSESSMENT OF STUDIES FOR EGCG OPPORTUNITIES IN NUTRACEUTICALS
  • TABLE 08: OPPORTUNITY FINDINGS OF EGCG IN COSMETICS
  • TABLE 09: EGCG APPLICATIONS IN ONCOLOGY
  • TABLE 10: EGCG APPLICATIONS IN CARDIOVASCULAR DISEASES
  • TABLE 11: EGCG APPLICATIONS IN METABOLIC DISORDERS
  • TABLE 12: EGCG APPLICATIONS IN INFLAMMATROY SKIN DISEASES
  • TABLE 13: EGCG APPLICATIONS IN NEURODEGENRATIVE DISEASES
  • TABLE 14: EGCG APPLICATIONS IN OBESITY
  • TABLE 15: CLINICAL TRIALS IN PHARMACEUTICALS
  • TABLE 16: CLINICAL TRIALS IN NUTRACEUTICALS
Back to Top